Related Experiment Video

Updated: Jun 5, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.3K

REPRIEVE informs on kidney disease in people with HIV

Giovanni Guaraldi1, Dean L Winslow2, Paolo Raggi3

  • 1Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

AIDS (London, England)
|December 6, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

489
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.6K

Related Experiment Videos

Last Updated: Jun 5, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.3K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

489
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.6K

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

53
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

63
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
63

Articles linked to this work by shared authors, journal, and citation graph.

Reshaping long COVID care through patient-reported needs.

BMC infectious diseases·2026

Temelimab versus placebo in patients with post-COVID condition.

Brain, behavior, and immunity·2026

COVID-19 Testing and Containment Strategies for Children in Congregate Housing Facilities in Texas, 2021-2023.

American journal of public health·2026

Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease.

The Lancet regional health. Europe·2026

Frailty and intrinsic capacity: integrating complementary concepts to promote healthy ageing and transformation of care.

Age and ageing·2026

Cognitive and fine motor performance in people above 65 years of age with and without HIV.

Scientific reports·2026

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

AIDS (London, England)·2026

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

AIDS (London, England)·2026

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

AIDS (London, England)·2026

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

AIDS (London, England)·2026

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

AIDS (London, England)·2026

Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.

AIDS (London, England)·2026

Perspectives of Traditional Healers, Religious Leaders, and Biomedical Providers on Depression and HIV Care in Rural Uganda.

AIDS and behavior·2026

Comparison of urodynamic outcomes by hysterectomy technique: A cross-sectional study.

Urologia·2026

Correction: Supplementation of Saussurea costus root alleviates sodium nitrite-induced hepatorenal toxicity by modulating metabolic profile, inflammation, and apoptosis.

Frontiers in pharmacology·2026

Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review.

Gout, urate, and crystal deposition disease·2026

Computational analysis of therapeutic potential for simplified Piper spp.- derived medicinal mixtures in anxiety, sleep, pain and seizure.

Frontiers in pharmacology·2026

Decoction-derived bioactive nanoparticles of Lycopodium japonicum Thunb. attenuate knee osteoarthritis by regulating MAPK/ERK signaling.

Naunyn-Schmiedeberg's archives of pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us